Start your own journey to clinic

Please provide us with a few details so that we can match you with the right expert in your field.

*Required

Thank you, your request has been received.

We're busy connecting you with an expert, who will be in touch as soon as possible.

Oops! Something went wrong while submitting the form. Please try again or email us at webenquiries@conceptlifesciences.com
Assay Card

Assay Card

heRG Inhibtion

In the intricate landscape of drug discovery, Concept Life Sciences places a spotlight on the human ether-a-go-go related gene (hERG) potassium channel—an indispensable player in cardiac repolarization within the heart. This voltage-gated ion channel, with its expansive inner cavity, proves highly susceptible to drug binding. However, inhibition of the hERG channel can lead to diminished function, precipitating Long QT Syndrome (LQTS) and potentially fatal cardiac arrhythmias. Recognizing the pivotal role of hERG in cardiovascular safety, we acknowledge that issues in this domain often lead to the attrition of drug candidates. Consequently, Concept Life Sciences advocates for the comprehensive testing of cardiac risk through the hERG ion channel during the drug discovery process. Our commitment lies in navigating these complexities, ensuring that the path to therapeutic advancements remains clear, precise, and, above all, safe.

Alternatively, search our entire resource library below

Show filters
View all
Category one
Category two
Category three
Category four
Search
Clear
Resource type
Clear
Related service line
Clear
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Tag
Showing 0 items
No results found.
There are no results with this criteria. Try changing your search.